Showing results (681-690 of 1,547) with videos related to
Sort By:
Pageof 155
Multiple Sclerosis and Related Disorders|April 11, 2024
Efficacy and safety of ocrelizumab in patients with relapsing multiple sclerosis: Real-world experience of two Swiss multiple sclerosis centersL Diem, A Ovchinnikov, C Friedli, et al.AIDS and Behavior|January 4, 2021
Evaluation of the Microbiome in Men Taking Pre-exposure Prophylaxis for HIV PreventionBryce K Perler, Elizabeth M Reinhart, Madeline Montgomery, et al.Archives of Dermatological Research|November 24, 2021
Association between baseline insulin resistance and psoriasis incidence: the Women's Health InitiativeAlfred A Chan, Houmin Li, Wendy Li, et al.Molecular Cancer Research : MCR|March 6, 2021
Qa-1b Modulates Resistance to Anti-PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen ProcessingXiao Zhang, Erich Sabio, Chirag Krishna, et al.SN Comprehensive Clinical Medicine|August 16, 2021
Evaluation of the Treatment Efficacy and Safety of Remdesivir for COVID-19: a Meta-analysisJun Tao, Rebecca Aristotelidis, Alexandra Zanowick-Marr, et al.Plos One|September 16, 2016
Supporting Risk Assessment: Accounting for Indirect Risk to Ecosystem ComponentsCathryn Clarke Murray, Megan E Mach, Rebecca G Martone, et al.The Journal of Antibiotics|March 1, 1979
Isolation and structure elucidation of a novel griseorhodinR M Stroshane, J A Chan, E A Rubalcaba, et al.FEMS Microbiology Letters|November 1, 1996
Involvement of calcium in interactions between gingival epithelial cells and Porphyromonas gingivalisK T Izutsu, C M Belton, A Chan, et al.Cell Cycle (Georgetown, Tex.)|June 9, 2009
14-3-3sigma and p21 synergize to determine DNA damage response following Chk2 inhibitionShasha Meng, Tali Arbit, Selvaraju Veeriah, et al.AIDS (London, England)|November 1, 2021
Novel population-level proxy measures for suboptimal HIV preexposure prophylaxis initiation and persistence in the USALorraine T Dean, Hsien-Yen Chang, William C Goedel, et al.Pageof 155